Large Molecule

Shire to Close U.S. Plasma Plant

Nov 04, 2016

BioPharma-Reporter

Shire says it is closing in December a plasma fractionating facility in Los Angeles, California, but remains positive it can successfully manage its post-Baxalta manufacturing network of 17 sites, according to an article in BioPharma-Reporter.

Shire's CEO Flemming Ornskov made the announcement during a conference call revealing its Q3 results and said the move was the first part of a "network strategy [which] will be laid out next year."

Read the full story